… was that aPL are a risk factor for incident stroke and that … risk factor for incident IS and two
Class I studies that did not. Seven Class II studies supported aPL as an independent risk factor …

… such as homocysteine, protein C and fibrinogen were in the normal range, even if higher as
compared with controls, whereas CRP, antiphospholipid antibodies and lupus anticoagulant …

… Interestingly, the excessive CV events observed in patients with APS are not fully
explained by these factors. In recent years, several novel non-traditional risk factors for the …

… ; b) the current knowledge on non-traditional manifestations associated with aPL; and c)
the … of aPL as diagnostic antibodies to considering them to be risk factors for clinical events. …

… A positive antiphospholipid antibody titer has been identified as being associated with
CVD related-mortality [6]. It is believed that the chronic inflammation may accelerate the …

… antiphospholipid antibodies (aPL) (lupus anticoagulant (LA), and/or anticardiolipin (aCL) and
anti-β2-glycoprotein 1 antibodies … syndrome is a constellation of cardiovascular risk factors, …

… antiphospholipid antibody syndrome (PAPS) is characterized by venous or arterial thrombosis
and positive antiphospholipid antibodies. … PAPS and no associated risk factors with that of …

… risks of arterial thrombosis, venous thrombosis, and pregnancy morbidities in a large cohort
of persistent antiphospholipid antibodies … Non-traditional APS risk factors, new biomarkers (ie…

… Hence, the search for additional risk factors is needed in the critical analysis of the individual
clinical setting in order to optimize the therapy. Third, a not negligible (notable) proportion …

… Independent of aPL, because of the increased incidence of traditional cardiovascular
disease (CVD) and non-traditional lupus-related risk factors, eg, inflammation, renal disease, or …